Misonix inks Chinese distro deal for BoneScalpel with Weigao Orthopedic
Misonix (NSDQ:MSON) said today it inked an exclusive distribution agreement with Shandong Weigao Orthopedic Device Company. Through the deal, Weigao Orthopedic will gain the rights to sell, market and...
View ArticleAvinger tumbles on Q4 revenue miss
Shares in Avinger (NSDQ:AVGR) dropped today after the medical device maker missed expectations on Wall Street with its 4th quarter results. The Redwood City, Calif.-based company posted losses of...
View ArticleCourt clears Caldera’s $12.3m transvaginal mesh settlement
A California federal judge last week approved a $12.3 million deal to settle a number of insurance claims over injuries allegedly caused by Caldera Medical’s transvaginal mesh. Caldera’s insurer,...
View ArticleRadiation shielding dev RadiAction Medical raises $6m
Medical device developer RadiAction Medical said today it closed a $5.7 million strategic A round to support its novel radiation shielding device. The round was led by HighGround Tairun Investment,...
View ArticleTerumo’s MicroVention touts low adverse composite outcomes in HydroCoil study
Terumo Corp. (TYO:4543) subsidiary MicroVention today released results from a study of its HydroCoil embolic system, touting that the trial met its primary and secondary endpoints and showed low...
View ArticlePhilips inks partnership deal with Phoenix Children’s Hospital
Royal Philips (NYSE:PHG) said today it inked a long-term $65 million strategic partnership with Phoenix Children’s Hospital, touting it as the 1st stand-alone children’s health system to ink such a...
View ArticleBrazilian ANVISA denies half of high risk medical device registrations in 2016
By Stewart Eisenhart, Emergo Group Nearly half of some higher-risk registro registration applications to Brazilian medical device regulator ANVISA were rejected in 2016, according to the agency’s own...
View ArticleIntersect ENT seeks FDA nod for Resolve steroid-releasing implant
Intersect ENT (NSDQ:XENT) said today that it submitted a New Drug Application to the FDA for its Resolve steroid-releasing implant to treat chronic sinusitis patients with recurrent sinus obstruction....
View ArticleVirta Health looks to reverse, not treat, Type II diabetes
Virta Health, founded by physicians and scientists from Stanford, MIT and Harvard, launched today with the goal to reverse Type II diabetes using its technology platform to enable personalized remote...
View ArticleStryker halts enrollment early in Trevo study on high probability of success
Stryker (NYSE:SYK) said today that it’s putting an early stop to enrollment in a clinical trial of its Trevo anti-stroke device after a review board decided there’s a high probability of success for...
View ArticlePacira prices $300m senior notes offering
Pacira Pharmaceuticals (NSDQ:PCRX) said today that it priced $300 million of convertible 2.375% senior notes due 2022 in a private placement to qualified institutional buyers. The Parsippany,...
View ArticleThe ideal process for launching your medical device in the UK: Interview with...
Welcome to the Medsider interview series, a regular feature at MassDevice. All interviews are conducted by Scott Nelson, Founder of Medsider and Group Director for WCG. We hope you enjoy them! Michael...
View ArticlePharmaJet, Serum Institute partner for needle-free MMR vaccine
PharmaJet inked a partnership with vaccine manufacturer Serum Institute of India to commercialize needle-free delivery of the MMR vaccine using the Stratis 0.5mL injection system. PharmaJet’s device is...
View ArticleNovo Nordisk approaches Global Blood Therapeutics for possible takeover
Insulin giant Novo Nordisk (NYSE:NVO) has reportedly approached Global Blood Therapeutics (NSDQ:GBT) to discuss a possible takeover. The U.S. biotech is reviewing its options with an investment bank,...
View ArticleVertiFlex closes $40m round to support expanded Superion commercialization
VertiFlex said today it closed a $40 million round of financing to support its Superion indirect decompression system designed to treat moderate lumbar spinal stenosis. The round was led by newly...
View ArticleHere’s how you heat up cold hearts—for transplantation
[Photo courtesy University of Minnesota]A University of Minnesota–led research team has successfully warmed large-scale animal heart valves and blood vessels that were previously preserved at low...
View ArticleTitan Medical prices $6m offering
Titan Medical (CVE:TMD) today priced an upcoming overnight equity offering, looking to raise $5.6 million. The Toronto-based robotic device developer is looking to offer units at 26¢ (CAD 35¢) per...
View ArticleHealthcare robots: 5 ways they are getting even better
MIT researchers last year altered a Nao robot and tried it out as a task scheduler in a labor ward at Boston’s Beth Israel Deaconess Medical Center. [Image courtesy of MIT]Think robots and...
View ArticleGlenmark wins FDA nod for Phase II study of nebulized tiotropium bromide
Glenmark Pharmaceuticals said today that the FDA approved its Investigational New Drug application for a Phase II study of its nebulized tiotropium bromide. The Mahwah, N.J.-based company plans to...
View ArticleFDA warns of off-label balloon angioplasty to treat autonomic disorders
The FDA today released a safety communication concerning risks associated with off-label balloon angioplasty procedures intended to treat autonomic dysfunction, warning of serious health risks and a...
View Article